Stay updated on Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial
Sign up to get notified when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.

Latest updates to the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no visible changes to the study page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded the MeSH term Malignant lymphoma, large B-cell, diffuse and a new external resource entry for the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.0%

- Check77 days agoChange DetectedA minor site revision update was added (Revision: v3.4.2) and the prior government funding/status notice was removed (Revision: v3.4.1), with no impact on study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedA site-wide funding/status notice was added and a PubMed publication reference related to the study was included. These updates do not change the core study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.